DYN FY 2015 Earnings — Dyne Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

DYNDyne Therapeutics, Inc.

$3B

FY 2015 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$842M-42.6% YoY

Gross Profit

-$1.2B-140.9% margin

Operating Income

$64M7.6% margin

Net Income

$50M5.9% margin

EPS (Diluted)

$0.40

Cash Flow

Operating Cash Flow

$94M

Free Cash Flow

-$181M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$11.5B

Total Liabilities

$8.6B

Stockholders' Equity

$2.9B

Cash & Equivalents

$505M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$842M	$1.5B	-42.6%
Gross Profit	-$1.2B	$321M	-469.5%
Operating Income	$64M	-$318M	+120.1%
Net Income	$50M	-$67M	+174.6%